Telo Genomics Corp. (TSXV:TELO)
0.0500
+0.0050 (11.11%)
At close: Mar 9, 2026
-56.52% (1Y)
| Market Cap | 5.02M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -2.62M |
| Shares Out | 100.43M |
| EPS (ttm) | -0.03 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 70,400 |
| Average Volume | 99,845 |
| Open | 0.0450 |
| Previous Close | 0.0450 |
| Day's Range | 0.0450 - 0.0500 |
| 52-Week Range | 0.0400 - 0.1300 |
| Beta | 0.18 |
| RSI | 52.00 |
| Earnings Date | Feb 25, 2026 |